We remain fully committed to delivering shareholder value and are proud of the
significant progress achieved throughout our transformation from component
supplier to product company. Q3 2025 marks the completion of this transition.
We encourage you to visit our new website to learn more about the new IDEX and
our world-class product line-up.
Q3 revenues were as expected; however, revenue is a lagging indicator. The
leading indicators - customer validation, product certification completion,
regulatory approvals, and order pipeline development - all moved in the right
direction during Q3.
We continue to deliver against our previously communicated targets while we
execute the strategy designed to generate the returns our investors deserve.
We are grateful for your continued support and commitment during this period
of strategic transition.
Since Q3 closing of the books, IDEX has received contract orders from Toshiba,
Emnovate, Advanced Card Systems and more to follow in Q4.
Operating expenses excluding Cost of materials and Depreciation were $1.8
million (adjusted for R&D it was $1.4 million) in the third quarter of 2025,
down 59%, compared to $4.5 million in the third quarter of 2024.
IDEX Biometrics' reports and presentations are available on our
website: Reports and presentations - IDEX Biometrics
(https://idexbiometrics.com/reports-and-presentations/)
IDEX Biometrics ASA's third quarter 2025 report and company presentation are
attached to this notice.
Contacts
Anders Storbråten, CEO and CFO, Tel: +47 416 38 582
E-mail: ir@idexbiometrics.com
About Us
IDEX Biometrics ASA (OSE: IDEX) is shaping the future of access and payments.
IDEX Biometrics is advancing the future of access and payments with
identity-first biometrics. With over a decade of proprietary innovation, our
solutions are proven in the field, globally certified, and trusted by leading
financial institutions. We serve enterprises, the public sector, banks, and
issuers directly and through partners, delivering secure, seamless experiences
in digital and physical access and payments.
For more information, visit www.idexbiometrics.com
(http://www.idexbiometrics.com/)
This information is subject to disclosure under the Norwegian Securities
Trading Act, §5-12. The information was submitted for publication at
2025-11-13 07:31 CET.